Maternal depression and prenatal exposure to methamphetamine: Neurodevelopmental findings from the Infant Development, Environment, and Lifestyle (IDEAL) study

Depression and Anxiety

Volumn 29, Issue 6, 2012, Pages 515-522

  Smith, Lynne M ^a   Paz, Monica S ^a   Lagasse, Linda L ^b   Derauf, Chris ^c,d   Newman, Elana ^e   Shah, Rizwan ^f   Arria, Amelia ^g   Huestis, Marilyn A ^h   Haning, William ^c   Strauss, Arthur ⁱ   Della Grotta, Sheri ^b   Dansereau, Lynne M ^b   Neal, Charles ^c   Lester, Barry M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF TULSA   (United States)

^f Blank Hospital Regional Child Protection Center Iowa Health   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

ⁱ MILLER CHILDREN S HOSPITAL   (United States)

Author keywords

amphetamine; antenatal; drug

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CHILD; CHILD DEVELOPMENT; FEMALE; HUMAN; INCIDENCE; INFANT; LIFESTYLE; MALE; MASS FRAGMENTOGRAPHY; MECONIUM; MENTAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SELF REPORT;

EID: 85027953230     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21956     Document Type: Article

References (50)

1. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434; 2009a. Ref Type: Pamphlet.
2. Substance Abuse and Mental Health Services Administration, O. o. A. S. Treatment Episode Data Set (TEDS) Highlights-2007 National Admissions to Substance Abuse Treatment Services. OAS Series #S-45, Publication No. (SMA) 09-4360. Rockville, MD: SAMHSA, Office of Applied Studies. 2009b Ref Type: Pamphlet.
3. Terplan M, Smith EJ, Kozloski MJ, Pollack HA,. Methamphetamine use among pregnant women. Obstet Gynecol 2009; 113: 1285-1291.
4. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 181-190. (Pubitemid 38585698)
5. Sekine Y, Iyo M, Ouchi Y, et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158: 1206-1214. (Pubitemid 32717692)
6. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001a; 158: 2015-2021. (Pubitemid 33104107)
7. Dunlop BW, Nemeroff CB,. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64: 327-337. (Pubitemid 46376789)
8. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR,. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698-709. (Pubitemid 40459031)
9. Burt VK, Stein K,. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002; 63 (Suppl 7): 9-15. (Pubitemid 34454034)
10. Sundermann EE, Maki PM, Bishop JR,. A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. Menopause 2010; 17: 874-886.
11. Harris B, Johns S, Fung H, et al. The hormonal environment of post-natal depression. Br J Psychiatry 1989; 154: 660-667. (Pubitemid 19154940)
12. Harris B,. Postpartum depression and thyroid antibody status. Thyroid 1999; 9: 699-703. (Pubitemid 29357914)
13. Marcus SM,. Depression during pregnancy: rates, risks and consequences-Motherisk update 2008. Can J Clin Pharmacol 2009; 16: e15-e22.
14. Warner R, Appleby L, Whitton A, Faragher B,. Demographic and obstetric risk factors for postnatal psychiatric morbidity. Br J Psychiatry 1996; 168: 607-611.
15. Weinberg MK, Tronick EZ,. Emotional characteristics of infants associated with maternal depression and anxiety. Pediatrics 1998; 102: 1298-1304.
16. Righetti-Veltema M, Bousquet A, Manzano J,. Impact of postpartum depressive symptoms on mother and her 18-month-old infant. Eur Child Adolesc Psychiatry 2003; 12: 75-83. (Pubitemid 36538412)
17. Diego MA, Field T, Hernandez-Reif M, Cullen C, Schanberg S, Kuhn C,. Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry 2004; 67: 63-80. (Pubitemid 38525863)
18. Lundy BL, Jones NA, Field T, et al. Prepartum depression effects on neonates. Infant Behav Dev 1999; 22: 121-137.
19. Smith LM, LaGasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 2008; 30: 20-28.
20. Paz MS, Smith LM, LaGasse LL, et al. Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol 2009; 31: 177-182.
21. Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118: 1149-1156. (Pubitemid 46090058)
22. Bauer CR, Shankaran S, Bada HS, et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002; 186: 487-495. (Pubitemid 34234162)
23. Lester BM, Tronick EZ, LaGasse L, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-1192. (Pubitemid 35425195)
24. Hollingshead AB,. Four factor index of social status. New Haven, CT: Department of Sociology, Yale University; 1975. Ref Type: Pamphlet.
25. Beck AT, Steer RA, Brown GK,. Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996b. Ref Type: Generic.
26. Beck AT, Brown G, Steer RA,. Beck Depression Inventory II Manual. San Antonio, TX: The Psychological Corporation; 1996a.
27. Gatewood-Colwell G, Kaczmarek M, Ames MH,. Reliability and validity of the Beck Depression Inventory for a white and Mexican-American gerontic population. Psychol Rep 1989; 65: 1163-1166. (Pubitemid 20117834)
28. Lester BM, Tronick EZ, Brazelton TB,. The neonatal intensive care unit network neurobehavioral scale procedures. Pediatrics 2004; 113: 641-667. (Pubitemid 38280776)
29. Brazelton TB,. Neonatal Behavioral Assessment Scale. Philadelphia, PA: JB Lippinicott; 1984. Ref Type: Generic
30. Finnegan LP,. Neonatal abstinence syndrome: assessment and pharamacotherapy. In:, Rubatelli FF, Granati B, editors. Neonatal Therapy and Update. New York, NY; Excerpta Medica; 1986. Ref Type: Generic.
31. Zabaneh R, Smith LM, LaGasse LL, et al. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol 2011; 29: 203-210.
32. Lester BM, &, Tronick EZ,. NICU Network Neurobehavioral Scale Manual. Baltimore, MD: Paul H. Brookes Publishing Co., Inc; 2005.
33. Marshall BD, Werb D,. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010; 105: 991-1002.
34. London ED, Simon SL, Berman SM, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004; 61: 73-84. (Pubitemid 38044643)
35. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001b; 158: 2015-2021. (Pubitemid 33104107)
36. Inaba A, Thoits PA, Ueno K, Gove WR, Evenson RJ, Sloan M,. Depression in the United States and Japan: gender, marital status, and SES patterns. Soc Sci Med 2005; 61: 2280-2292. (Pubitemid 41446234)
37. Kavanaugh M, McMillen RC, Pascoe JM, Hill SL, Winickoff JP, Weitzman M,. The co-occurrence of maternal depressive symptoms and smoking in a national survey of mothers. Ambul Pediatr 2005; 5: 341-348. (Pubitemid 41782577)
38. Grace SL, Evindar A, Stewart DE,. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Women Ment Health 2003; 6: 263-274. (Pubitemid 37484381)
39. Galler JR, Harrison RH, Ramsey F, Forde V, Butler SC,. Maternal depressive symptoms affect infant cognitive development in Barbados. J Child Psychol Psychiatry 2000; 41: 747-757.
40. Milgrom J, Westley DT, McCloud, P,. I. Do infants of depressed mothers cry more than other infants? J Paediatr Child Health 1995; 31: 218-221.
41. Sinclair D, Murray L,. Effects of postnatal depression on children's adjustment to school. Teacher's reports. Br J Psychiatry 1998; 172: 58-63. (Pubitemid 28122529)
42. Cox AD, Puckering C, Pound A, Mills M,. The impact of maternal depression in young children. J Child Psychol Psychiatry 1987; 28: 917-928. (Pubitemid 18044813)
43. Malphurs JE, Field T, Larraine C, Pickens J, Pelaez-Nogueras M, Bendell D,. Altering withdrawn and instrusive interaction behaviors of depressed mothers. Infant Mental Health J 1996; 17: 152-160. (Pubitemid 126458879)
44. Lyons-Ruth K, Zoll D, Connell D, Grunebaum HU,. The depressed mother and her one-year-old infant: environment, interaction, attachment, and infant development. New Dir Child Dev 1986; 34: 61-82.
45. Cicchetti D, Toth SL,. A developmental perspective on internalizing and externalizing disorders. In:, Cicchetti D, Toth SL, editors. Internalizing and Externalizing Expressions of Dysfunction. London: Psychology Press; 1998.
46. Salisbury AL, Lester BM, Seifer R, et al. Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol 2006; 29: 331-340.
47. Sighvatsson MB, Kristjansdottir H, Sigurdsson E, Sigurdsson JF,. Efficacy of cognitive behavioral therapy in the treatment of mood and anxiety disorders in adults. Laeknabladid 2011; 97: 613-619.
48. Hollon SD, Ponniah K,. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety 2010; 27: 891-932.
49. Nahas R, Sheikh O,. Complementary and alternative medicine for the treatment of major depressive disorder. Can Fam Physician 2011; 57: 659-663.
50. Chang T, Fava M,. The future of psychopharmacology of depression. J Clin Psychiatry 2010; 71: 971-975.